RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1411
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_1438600; Gene model (P.falciparum): PF3D7_1223700; Gene product: vacuolar iron transporter (VIT)
Phenotype Asexual bloodstage; Liver stage;
Last modified: 6 April 2016, 07:26
  *RMgm-1411
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 26786069
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 2.34
Other information parent lineP. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943).
The mutant parasite was generated by
Name PI/ResearcherSlavic K; Mota MM
Name Group/DepartmentInstituto de Medicina Molecular
Name InstituteFaculdade de Medicina Universidade de Lisboa
CityLisbon
CountryPortugal
Name of the mutant parasite
RMgm numberRMgm-1411
Principal namePbvit-
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageReduced growth/multiplication of asexual blood stages.
Parasitemias in Pbvit- infected mice were significantly reduced, when compared with those in mice infected with wild-type (wt) parasites. Furthermore, C57Bl/6 J mice infected with Pbvit- parasites (104 infected RBC i.v.) survived significantly longer compared with mice infected with wt parasites.
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageReduced liver stage development.
A significant reduction in parasite liver load was detected after Pbvit- sporozoite infection. The observed reduction in parasite liver load was due to a lower number of infected hepatocytes, as well as moderate reduction in size of developing Pbvit- exoerythrocytic parasite forms—EEFs.
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of VIT

Protein (function)
Appropriate storage of any excess of iron, which is not used metabolically, is essential to prevent cellular toxicity due to engagement of iron in Fenton-type chemistry in the presence of oxygen and production of potentially damaging reactive oxygen species. Ferritin represents the most common and ancient mechanism of iron storage and homeostasis in nature, as it is found in most bacteria, archaea, plants and animals, but not in yeast. In the absence of ferritin, the yeast vacuole serves as the main iron-storage/sequestration organelle. In response to demands, iron moves to and from the yeast vacuole through the activity of iron transporters in the yeast vacuolar membrane; CCC1 (Ca2+-sensitive cross complementer 1) is proposed to import iron, while a complex constituted by Smf3p and Fet5p-Fth1p exports iron. Thus, vacuolar sequestration by CCC1 in yeast is likely to be the primary mechanism for detoxification of excess iron in this organism. In addition to ferritin found in plastids, plants also have several homologues of CCC1, named vacuolar iron transporters (VITs), which are likely to transport not only iron but also other divalent cations such as manganese and zinc into the vacuole for storage and detoxification.
Plasmodium parasites do not contain a homologue of ferritin or any other known iron-storage protein. However, Plasmodium spp. genomes contain one orthologue of plant VIT and yeast CCC1 proteins.

Phenotype
Reduced growth/multiplication of asexual blood stages. Reduced liver stage development.

Additional information
Evidence is presented that VIT plays a role in iron transport, suggesting that it plays a role in iron detoxification.

Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1438600
Gene Model P. falciparum ortholog PF3D7_1223700
Gene productvacuolar iron transporter
Gene product: Alternative nameVIT
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1taGGTACCTATTTCTATATATGTTTCCG
Additional information primer 1PbVIT-KO5’f
Sequence Primer 2TAGGGCCCTCTTTTTATTTTATTATTGCC
Additional information primer 2PbVIT-KO5’r
Sequence Primer 3tcGATATCAGAGTTTAAGAATGTGGAATG
Additional information primer 3PbVIT-KO3’f
Sequence Primer 4ATGCGGCCGCGTATAGTTACACAATACATG
Additional information primer 4PbVIT-KO3’r
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6